Pacira Pharmaceuticals reported $792.58M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 58.97M 12.34M
Adamas Pharmaceuticals ADMS:US 115.66M 42.45M
Aerie Pharmaceuticals AERI:US $ 289.02M 4.56M
Amerisourcebergen ABC:US $ 37259.77M 1790.62M
Antares Pharma ATRS:US $ 127.96M 5.56M
Astellas Pharma 4503:JP Y 868715M 3873M
Biodelivery Sciences International BDSI:US $ 196.06M 9.92M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Cara Therapeutics CARA:US $ 164.47M 23.88M
Coherus Biosciences CHRS:US $ 660.01M 42.75M
Depomed DEPO:US $ 119.35M 4.72M
Endo International Ordinary Shares ENDP:US $ 2569.33M 74.1M
Flexion Therapeutics FLXN:US $ 184.12M 20.5M
Heron Therapeutics HRTX:US $ 366.83M 94.54M
Horizon Pharma HZNP:US $ 2175.38M 344.01M
Ironwood Pharmaceuticals IRWD:US $ 620.27M 82.02M
JAZZ PHA JAZZ:US $ 2953.96M 212.93M
Lannett LCI:US $ 353.56M 16.35M
Ligand Pharmaceuticals LGND:US $ 410.9M 26.53M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Omeros OMER:US $ 112.4M 20.08M
Pacira Pharmaceuticals PCRX:US $ 792.58M 72.33M
Perrigo Ordinary Shares PRGO:US $ 4420.2M 68.4M
Revance Therapeutics RVNC:US $ 354.6M 51.82M
Supernus Pharmaceuticals SUPN:US $ 639.24M 53.22M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Xeris Pharmaceuticals Inc XERS:US $ 144.59M 16.04M
Xoma XOMA:US $ 87.25M 17M
Zoetis ZTS:US $ 7048M 254M